Stock listing

OTC:ONPH Oncology Pharma Inc. Stock

Follow Oncology Pharma Inc. into a list and get an email when it puts out news.

Share price · OTC:ONPH

$0.037 USD -0.004 (-8.6%)

Close on Nov 20, 2026

Past year +7,300% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.037 – $0.050 USDNov 20, 2026
Volume
8,534 sharesNov 20, 2026
Market cap
$3.04M USDAt the close on Nov 20, 2026 · price × 82.16M shares outstanding
52-week range
$0.0009 – $0.364 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$618 USDMedian day 7,661 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Oncology Pharma Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:ONPH · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.037-0.004-8.6%$0.037$0.050$0.0378,534
$0.041+0.004+9.5%$0.037$0.041$0.0379,604
$0.037-0.004-8.6%$0.037$0.049$0.0379,645
$0.041+0.005+12.5%$0.036$0.041$0.0363,037
$0.036-0.008-18.2%$0.040$0.045$0.036125,258
$0.044+0.004+10.0%$0.044$0.044$0.0405,334
$0.0400.0000.0%$0.040$0.040$0.0403,701
$0.0400.0000.0%$0.040$0.050$0.04027,631
$0.0400.0000.0%$0.052$0.052$0.0408,490
$0.040-0.005-11.1%$0.040$0.050$0.0406,220
$0.045+0.005+12.5%$0.040$0.050$0.04016,326
$0.0400.0000.0%$0.040$0.050$0.0403,901
$0.040-0.008-16.5%$0.040$0.052$0.04048,731
$0.048+0.008+19.7%$0.046$0.048$0.0408,159
$0.040+0.004+11.1%$0.040$0.048$0.03013,520
$0.036+0.006+19.6%$0.031$0.036$0.0312,023
$0.030-0.016-34.6%$0.030$0.035$0.0307,383
$0.046-0.002-4.2%$0.030$0.046$0.0308,590
$0.0480.0000.0%$0.035$0.048$0.0358,765
$0.048+0.013+37.1%$0.048$0.048$0.03617,268
$0.0350.0000.0%$0.041$0.048$0.0332,653
$0.035+0.004+13.6%$0.035$0.052$0.0333,283
$0.031-0.010-24.3%$0.041$0.041$0.0311,445
$0.041-0.011-21.7%$0.041$0.052$0.0415,543
$0.052-0.004-7.0%$0.031$0.052$0.0307,953
$0.056-0.004-6.1%$0.030$0.060$0.03036,293
$0.060+0.009+19.0%$0.030$0.060$0.0303,669
$0.050+0.020+66.1%$0.030$0.054$0.0308,709
$0.030-0.020-39.8%$0.050$0.055$0.03015,611
$0.050+0.020+66.7%$0.030$0.060$0.0307,071
$0.030-0.020-39.4%$0.030$0.045$0.0306,650
$0.050+0.020+65.0%$0.030$0.050$0.0304,193
$0.030-0.024-44.9%$0.030$0.054$0.03015,879
$0.054-0.006-9.3%$0.052$0.054$0.03021,058
$0.060+0.016+35.4%$0.030$0.062$0.03015,217
$0.044+0.010+30.3%$0.045$0.045$0.0445,724
$0.034-0.028-45.2%$0.062$0.062$0.03423,376
$0.062-0.003-4.5%$0.030$0.062$0.0302,644
$0.065+0.025+62.2%$0.068$0.068$0.0317,661
$0.040-0.010-20.0%$0.050$0.050$0.04024,957
$0.050-0.001-2.0%$0.050$0.059$0.05012,875
$0.051+0.001+2.0%$0.064$0.068$0.0506,130
$0.050-0.002-3.8%$0.052$0.064$0.020125,795
$0.0520.000-0.2%$0.069$0.069$0.0527,783
$0.0520.0000.0%$0.052$0.052$0.052608
$0.052-0.016-23.4%$0.052$0.052$0.0521,118
$0.068+0.017+32.8%$0.052$0.068$0.0523,140
$0.051+0.000+0.4%$0.051$0.069$0.05127,274
$0.0510.000-0.8%$0.069$0.069$0.05113,840
$0.051+0.000+0.4%$0.051$0.065$0.0515,107
$0.051-0.014-21.2%$0.069$0.069$0.0514,410
$0.065+0.000+0.2%$0.054$0.069$0.0514,609
$0.0650.000-0.2%$0.050$0.065$0.0505,146
$0.065+0.000+0.2%$0.050$0.069$0.05010,553
$0.065-0.003-4.4%$0.068$0.068$0.0518,898
$0.068+0.013+23.5%$0.050$0.068$0.05020,609
$0.055+0.003+5.8%$0.069$0.069$0.05114,974
$0.0520.000-0.6%$0.050$0.069$0.0505,848
$0.052+0.001+2.5%$0.060$0.060$0.0513,391
$0.0510.0000.0%$0.051$0.051$0.051513
$0.0510.0000.0%$0.051$0.051$0.0516,354
$0.051-0.001-2.5%$0.051$0.051$0.0512,963
$0.052+0.001+2.5%$0.051$0.069$0.05111,768
$0.051-0.001-2.5%$0.069$0.069$0.0511,089
$0.052+0.001+2.5%$0.052$0.052$0.0515,991

Splits

4 splits since 1999 · OTC:ONPH · every price before a split is adjusted for it

DayRatioWhat
1-for-100Consolidation
1-for-10000Consolidation
1-for-500Consolidation
1-for-4Consolidation
Ticker
OTC:ONPH
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

Latest news

All Oncology Pharma Inc. news

Oncology Pharma Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
115 in all · newest Jul 12, 2022 · oldest 2012

Valuation

Statements: Year to Mar 31, 2026 · price Nov 20, 2026

Enterprise value
Not reported
P/E
Loss
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Not reported
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
Not reported
Beta vs S&P 500
1.62

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Oncology Pharma Inc. · OTC:ONPHUS$3.04Mn/an/an/an/an/an/an/a1.62
Spago Nanomedical AB · OMXSTO:SPAGOUS$3.20MUS$22,063n/a5.6×n/a1.0×n/a0.0×n/a
Kiora Pharmaceuticals, Inc. · NASDAQ:KPRXUS$3.19M−US$12.81Mn/a−12.8×n/a0.2×n/a0.0×1.54
Azitra Inc · AMEX:AZTRUS$3.13M−US$618,677n/an/an/a0.7×n/a0.0×0.60
NuCana plc · NASDAQ:NCNAUS$3.12M−US$21.37Mn/an/an/a0.1×n/a0.0×1.58
Revive Therapeutics Ltd. · CSE:RVVUS$3.10MUS$3.14Mn/an/an/an/an/an/a0.56
Skye Bioscience, Inc. · NASDAQ:SKYEUS$3.10M−US$1.71Mn/an/an/a2.3×n/a0.0×0.85
Creative Medical Technology Holdings, Inc. · NASDAQ:CELZUS$3.06M−US$3.79Mn/a−1,263×n/a0.4×n/a0.0×1.53
Imunon, Inc. · NASDAQ:IMNNUS$3.00MUS$5.90Mn/an/an/a1.1×n/a2.6×0.57
Gelteq Limited · NASDAQ:GELSUS$2.89MUS$6.27Mn/a57.2×n/a0.3×n/a0.4×0.83
Curis, Inc. · NASDAQ:CRISUS$2.85M−US$1.42Mn/an/an/a1.1×n/a0.3×1.85
Median of the othersUS$3.10M−US$1.02M−3.6×0.7×0.0×0.85

Financials

Annual, in USD

Income statement

LineFY2026FY2023FY2022FY2021FY2020FY2019FY2013FY2011FY2004FY2003
Revenue10.2K134.7K1.18M3.28M
Cost of revenue7791.11K1.11K654.0K1.21M
Gross profit-779-1.11K-1.11K10.2K134.7K527.0K2.07M
Research and development376.0K780.0K
Selling, general and administrative18.9K19.2K1.85M2.91M
Operating income-5.82K-62.0K-14.4M-403.9K-818.9K-14.5K59.5K-1.70M-1.63M
Depreciation and amortization228.5K236.6K7791.11K1.11K5.82K5.82K81.0K395.0K
EBITDA174.5K-14.4M-402.8K-817.8K-8.65K65.3K-1.62M-1.23M
Interest expense104.6M82.8M25.0K31.5K0000
Income before tax-5.82K-104.6M-97.5M-207.6K-850.4K-14.5K59.5K-1.57M-1.54M
Income tax-236.6K3.49K11800800-136.0K-105.0K
Net income-5.82K-104.6M-97.5M-207.6K-850.4K186.0K58.7K-1.56M-1.52M
Earnings per share, basic-0.00-3.42-6.76-0.12-0.72

Balance sheet

LineFY2026FY2023FY2022FY2021FY2020FY2019FY2013FY2011FY2004FY2003
Cash and equivalents3.96K8.95K1.80K6.71K9.31K8.00K1.35M
Receivables15.0K19.0K19.0K
Inventory177.6K150.2K
Current assets3.96K8.95K1.80K6.71K186.9K165.2K48.0K1.58M
Property, plant and equipment6.32K62.0K129.0K
Total assets2.12M347.6K230.9K190.5K198.6K262.2K48.0K1.75M
Accounts payable7.16K10.8K195.0K195.0K
Current liabilities875.5K517.6K294.5K403.2K213.0K666.4K220.0K879.0K
Long-term debt205.9K
Total debt662.1K238.4K129.4K238.1K25.0K
Total liabilities875.5K517.6K294.5K403.2K418.9K666.4K220.0K879.0K
Shareholders' equity1.25M-170.0K-63.7K-212.6K-220.3K-404.3K-172.0K872.0K
Shares outstanding82.2M38.6M30.6M14.4M1.68M1.19M21

Cash flow

LineFY2023FY2022FY2021FY2020FY2019FY2013FY2011FY2004FY2003
Cash from operations368.6K-117.1K-22.4K-36.9K7.06K7.06K-2.00M-1.44M
Capital spending00-400-6.32K-6.32K-17.0K-147.0K
Free cash flow368.6K-117.1K-22.4K-36.9K740740-2.02M-1.59M
Cash from investing-1.78M-321.9K186.5K186.5K116.0K-145.0K
Cash from financing1.41M446.2K17.5K42.9K205.9K205.9K546.0K1.00K
Change in cash-4.99K7.15K-4.90K5.98K12.4K12.4K-1.34M-1.59M

Open Financials

Cap table

Built by 6ix from Oncology Pharma Inc.’s releases

Common shares
82,164,642
Fully diluted
82,164,642

Fully diluted

LineShares
Common shares82,164,642

Share count over time

CountShares
Nov 22, 202682,164,642

Open Cap table

Shareholders

HolderSharesOf the companyValueAs of
Ascentis Independent Advisors200<0.01%US$6Sep 30, 2026
Hantz Financial Services, Inc.121<0.01%Sep 30, 2026
Estabrook Capital Management50<0.01%US$2Sep 30, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about Oncology Pharma Inc.